Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Electrical Stimulation of the Brain Alleviates Tinnitus

By HospiMedica staff writers
Posted on 07 Jan 2008
Chronic electrical stimulation of the secondary auditory cerebral cortex could eventually become a potential therapeutic intervention for the suppression of tinnitus.

Researchers at the Medical College of Wisconsin (Milwaukee, USA) conducted a study of cortical stimulation involving eight adult patients with constant tinnitus of at least one year, with a tinnitus reaction questionnaire score greater than 33 (tinnitus was predominantly unilateral with a frequency less than 8,000 Hz). More...
An investigational epidural electrode was surgically implanted over the posterior superior temporal gyrus using functional magnetic resonance imaging targeting. A two-week stimulation period alternated with a two-week sham period in random order to which subjects were blinded. This was followed by continuous stimulation with parameter adjustments to maximize tinnitus suppression. The main outcome measures were subjective rating of tinnitus severity, loudness, and device efficacy, and objective measures of hearing thresholds, tinnitus frequency, loudness, and minimum masking levels.

The results showed there were no effects of stimulation during the four-week blinded period. With continuous chronic stimulation, two patients had persistent reduction of pure-tone tinnitus, and six patients had short periods of total tinnitus suppression. Significant improvements in the Beck Depression Inventory and tinnitus questionnaires were found, although objective measures of tinnitus loudness remained fairly stable. No surgical or stimulation-related complications were noted.

"Whether the effect is durable over the long run remains to be seen,” said lead author neurosurgeon Brian Kopell, M.D. "However, once the kinks are worked out, millions of people could someday benefit from surgery.”

Neurostimulator devices are programmed to deliver an electrical current through an implanted electrode to stimulate targeted nerve cells and nerve fibers in the brain, spinal cord, and peripheral nerves. Targeting neurologic problems at their source can be very effective in regulating or reducing chronic pain and other disorders of the central nervous system.


Related Links:
Medical College of Wisconsin

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.